Search Results 1341-1350 of 3914 for Solid

1. A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared with Placebo for the Treatment of Participants with Mycobacterium Avium Complex (MAC) Pulmonary Disease - Mayo Clinic

   solid agar 4. Is either treatment naïve and has not received any prior treatment for MAC, OR if previously treated for MAC and meets all of the following ...

2. Clinical trials - Oncology (Medical)

   Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of ...

3. Hypertrophic cardiomyopathy - Symptoms and causes - Mayo Clinic

   In this condition, the heart muscle thickens, which makes it harder for the heart to pump blood. Learn about the causes and treatment.

4. Futibatinib and Pembrolizumab for the Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer - Mayo Clinic

   Measurable disease by any imaging modality as defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria in at least one site not previously ...

5. Does sunscreen expire? - Mayo Clinic

   That means you can use leftover sunscreen from one year to the next. Some sunscreens include an expiration date — the date when they're no longer effective.

6. CTX131 in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Prior solid organ or allogeneic BM transplantation, except for AML cohorts if at least 3 months since allogeneic HSCT, not receiving immunosuppressive ...

7. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

   Prior solid organ transplantation. Prior therapy with any known inhibitor of MNK1 orMNK2. Ongoing immunosuppressive therapy, including systemic or enteric ...

8. Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors - Mayo Clinic

   ... Solid Tumors (RECIST) version (v)1.1 criteria in the 12 months prior to registration; the radiologic images, imaging reports, and clinic notes indicating ...

9. Clinical trials - Oncology (Medical)

   ... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter ...

10. A Study of Poziotinib in Patients with NSCLC With EGFR or HER2 Exon 20 Insertion Mutation - Mayo Clinic

    Patient has measurable NSCLC disease, as per the Response Evaluation Criteria in Solid Tumors (RECIST, version 1.1). Metastatic lesions in CNS or in brain ...